337 related articles for article (PubMed ID: 32452356)
1. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.
Dennis M; Forbes J; Graham C; Hackett M; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G
Health Technol Assess; 2020 May; 24(22):1-94. PubMed ID: 32452356
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.
FOCUS Trial Collaboration
Lancet; 2019 Jan; 393(10168):265-274. PubMed ID: 30528472
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.
Mead G; Hackett ML; Lundström E; Murray V; Hankey GJ; Dennis M
Trials; 2015 Aug; 16():369. PubMed ID: 26289352
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
EFFECTS Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
AFFINITY Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
[TBL] [Abstract][Full Text] [Related]
8. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis.
Graham C; Lewis S; Forbes J; Mead G; Hackett ML; Hankey GJ; Gommans J; Nguyen HT; Lundström E; Isaksson E; Näsman P; Rudberg AS; Dennis M
Trials; 2017 Dec; 18(1):627. PubMed ID: 29282099
[TBL] [Abstract][Full Text] [Related]
9. Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.
Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q;
Stroke; 2021 Aug; 52(8):2502-2509. PubMed ID: 34015940
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
11. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
[TBL] [Abstract][Full Text] [Related]
12. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial.
Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201
[TBL] [Abstract][Full Text] [Related]
13. Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT.
Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Finch T; Alvarado N; Ternent L; Fernandez-Garcia C; Aird L; Andole S; Cohen DL; Dawson J; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Turner DL; Vale L; Wilkes S; Shaw L
Health Technol Assess; 2020 Oct; 24(54):1-232. PubMed ID: 33140719
[TBL] [Abstract][Full Text] [Related]
14. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
15. A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial.
Langhorne P; Wu O; Rodgers H; Ashburn A; Bernhardt J
Health Technol Assess; 2017 Sep; 21(54):1-120. PubMed ID: 28967376
[TBL] [Abstract][Full Text] [Related]
16. Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT.
Witham MD; Band M; Chong H; Donnan PT; Hampson G; Hu MK; Littleford R; Lamb E; Kalra PA; Kennedy G; McNamee P; Plews D; Rauchhaus P; Soiza RL; Sumukadas D; Warwick G; Avenell A
Health Technol Assess; 2020 Jun; 24(27):1-90. PubMed ID: 32568065
[TBL] [Abstract][Full Text] [Related]
17. Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.
Benger JR; Kirby K; Black S; Brett SJ; Clout M; Lazaroo MJ; Nolan JP; Reeves BC; Robinson M; Scott LJ; Smartt H; South A; Stokes EA; Taylor J; Thomas M; Voss S; Wordsworth S; Rogers CA
Health Technol Assess; 2022 Apr; 26(21):1-158. PubMed ID: 35426781
[TBL] [Abstract][Full Text] [Related]
18. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
20. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
